We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Anirban Mitra

Anirban P. Mitra MD, PhD

1Urologic Oncology Fellow, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Anirban P. Mitra, MD, PhD, is a Fellow in Urologic Oncology in the Department of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas. After earning his medical degree from the University of Mumbai, India, Dr. Mitra received a PhD from the University of Southern California in Los Angeles, California, where he investigated the molecular mechanisms driving bladder cancer development and progression. He subsequently completed his urologic surgery residency at the University of Southern California and Los Angeles County Medical Center. Dr. Mitra’s clinical interests encompass all aspects of urologic oncology, and he performs open, laparoscopic, and robotic surgery, tailored to the individual needs of patients with genitourinary cancers. His research is focused on the elucidation of cellular pathways of tumor progression and response to therapy, with a special focus on bladder cancer. His translational studies use computational and bioinformatic approaches to integrate laboratory observations with clinicopathologic and high-throughput molecular data to identify unique characteristics of tumors and flag therapeutic targets. Dr. Mitra has authored over 80 articles, including original research, book chapters and reviews, and holds patents for bladder cancer-related technologies. He is on the Editorial Boards of five journals, and serves as a reviewer for several scientific journals and funding organizations. Dr. Mitra has served on two bladder cancer committees for the International Consultation on Urologic Diseases.